BD Collaborates with U.S. Government to Develop COVID-19 Diagnostics
BARDA will invest $24.7 million for BD to develop five new COVID-19 combination diagnostic tests for core labs, hospitals, and point-of-care locations.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Covid 19, Immunoassay Reagents & test Kits |
BARDA will invest $24.7 million for BD to develop five new COVID-19 combination diagnostic tests for core labs, hospitals, and point-of-care locations.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Covid 19, Flu & Respiratory Infections, Immunoassay Reagents & test Kits |
The Aptima SARS-CoV-2/Flu Assay from Hologic tests simultaneously for SARS-CoV-2, influenza A, and influenza B on the Panther molecular diagnostics system.
Read MorePosted by Chris Wolski | Oct 27, 2021 | Covid 19, POC Rapid Assays |
Shipments are now available for the BD Veritor At-Home COVID-19 Test, an over-the-counter COVID-19 rapid antigen test.
Read MorePosted by Chris Wolski | Oct 26, 2021 | Covid 19 |
Glycans (sugars) can be used to detect COVID-19 infection from swab samples, according to researchers in the UK.
Read MorePosted by Chris Wolski | Oct 26, 2021 | Colorectal |
A survey of colorectal cancer screening patients found a preference for at-home fecal occult blood testing over colonoscopy during the COVID-19 pandemic.
Read More